The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study.

MLA

Van Obbergh, Florence, et al. “The Clinical Relevance of Imatinib Plasma Trough Concentrations in Chronic Myeloid Leukemia. A Belgian Study.” Clinical Biochemistry, vol. 50, no. 7–8, May 2017, pp. 452–54. EBSCOhost, https://doi.org/10.1016/j.clinbiochem.2016.12.006.

APA

Van Obbergh, F., Knoops, L., Devos, T., Beguin, Y., Graux, C., Benghiat, F., Kargar-Samani, K., Bauwens, D., Efira, A., Dubois, C., Springael, C., Montfort, L., Connerotte, T., Capron, A., Delannoy, A., & Wallemacq, P. (2017). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry, 50(7–8), 452–454. https://doi.org/10.1016/j.clinbiochem.2016.12.006

Chicago

Van Obbergh, Florence, Laurent Knoops, Timothy Devos, Yves Beguin, Carlos Graux, Fleur Benghiat, Khalil Kargar-Samani, et al. 2017. “The Clinical Relevance of Imatinib Plasma Trough Concentrations in Chronic Myeloid Leukemia. A Belgian Study.” Clinical Biochemistry 50 (7–8): 452–54. doi:10.1016/j.clinbiochem.2016.12.006.